Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsBlue Cross MA Non-Covered Drug Coverage | OpenPaye…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - MassachusettsPolicy 433

    Non-Covered Drug List & Non-Covered Formulary Exception

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Massachusetts Policy 433 alerts

    Get alerted when Policy 433 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs prior authorization and formulary exception requests for non-covered or non-formulary prescription drugs under applicable Blue Cross Blue Shield of Massachusetts commercial pharmacy benefits, including coverage criteria, documentation, formulary alternative trials, and the Non-covered Drug List.

    Policy Summary
    PayerBlue Cross Blue Shield - Massachusetts
    PolicyNon-Covered Drug List & Non-Covered Formulary Exception
    Policy CodePolicy 433
    Change TypeNo material change
    Effective DateAug 1, 2026
    Next Review DateN/A
    Key ActionSubmit a prior authorization and formulary exception request for coverage of a non-covered or non-formulary drug.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2Covered alternatives generally required when available
    1Covered alternative required when only one is available
    24 monthsApproval duration when an exception is authorized
    Highest copaymentCost-share level if an exception is authorized

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Commercial RxBenefit scope

    Coverage Criteria

    Successful maintenance

    A non-formulary drug may be determined medically necessary when the member meets ONE successful-maintenance pathway.

    Successful maintenance pathways

    • Current regimen maintenance: The provider establishes through documented clinical records or medication history that the member has been successfully maintained on the current medication regimen and that changing to a formulary alternative would result in instability of the medical condition.

      Documentation supporting the clinical justification is required.

    • Device-related test strips: The member is actively using a medical device, such as a continuous subcutaneous insulin infusion pump, and requires non-covered diabetic test strips.

    Non-maintained member exception criteria

    If the member is not successfully maintained on the requested non-covered medication, the following criteria must be met:

    Base clinical requirement: The requested drug is for an FDA-approved indication or an indication supported by current literature compendia, accepted treatment guidelines, or peer-reviewed standard of care.

    Additional qualifying pathway

    • Combination medication trial: For a non-covered combination medication, the member has tried the individual ingredients together when available and covered, or preferred drugs in the same therapeutic class when the individual agents are non-covered, including over-the-counter alternatives.
    • Covered alternative failure: If formulary alternatives are available, the member has tried and failed at least two covered alternatives, or one covered alternative if only one is covered within the same therapeutic class for the diagnosis.2 alternatives, or 1 when only one is covered

      Failure may include inadequate treatment response, intolerance, clinical contraindication, allergic reaction, or adverse reaction. Documentation must identify the alternative name and strength, the specific treatment failure, and any clinical reason preventing a formulary trial.

    Non-covered Drug List

    Products listed in the Non-covered Drug List are not covered.

    Non-covered product listing: The requested drug or product appears in the policy's Non-covered Drug List.

    The list includes individual brand names, generic names, strengths, dosage forms, kits, and other authorized products across multiple therapeutic categories.

    Investigational services or drugs are identified as an other policy condition and are not eligible for coverage under this policy.

    Services or drugs that are not medically necessary are identified as an other policy condition and are not eligible for coverage under this policy.

    Products identified on the policy’s Non-covered Drug List are excluded from coverage. The list includes prescription drugs, biologics, diabetic supplies, therapeutic products, and other pharmacy products across multiple therapeutic categories.

    Products in the proton pump inhibitor (PPI) grouping are excluded for members 18 years and older.

    Services or drugs determined to be not medically necessary are subject to the policy’s non-coverage conditions.

    Initial Non-Covered Drug Exception

    Initial non-covered drug exception

    For a member not successfully maintained on the requested medication, an initial exception may be considered when the following requirements are satisfied:

    Initial exception requirements

    • Supported indication: The requested drug is for an FDA-approved indication or an indication supported by current literature compendia, accepted treatment guidelines, or peer-reviewed standard of care.
    • Applicable exception pathway

      • Combination medication trial: For a non-covered combination medication, the member has tried the individual ingredients together when available and covered, or preferred drugs in the same therapeutic class when the individual agents are non-covered, including over-the-counter alternatives.
      • Covered alternative failure:

    Successful Maintenance Continuation

    Successful maintenance continuation

    Coverage may be authorized for a non-formulary drug when the member meets ONE successful-maintenance pathway.

    Continuation pathways

    • Current regimen maintenance: The provider documents through clinical records or medication history that the member has been successfully maintained on the current medication regimen and that changing to a formulary alternative would result in instability of the medical condition.

      Documentation supporting the clinical justification is required.

    • Device-related test strips: The member is actively using a medical device, such as a continuous subcutaneous insulin infusion pump, and requires non-covered diabetic test strips.

    Formulary Alternative Requirements

    Step-therapy requirementCovered alternatives requiredDocumentation or exception pathway
    Formulary alternatives availableTry and fail at least 2 covered alternativesDocument the name and strength of each alternative and the specific treatment failure, such as inadequate response, intolerance, contraindication, allergic reaction, or adverse reaction.
    Only 1 formulary alternative is covered in the same therapeutic class for the diagnosisTry and fail 1 covered alternativeIf the member cannot be switched, document the clinical reason preventing the trial or the basis for instability, such as a narrow therapeutic index medication.

    Submission and Documentation Requirements

    Prior Authorization

    Submit a Formulary Exception Request

    Submit a Formulary Exception/Prior Authorization request before seeking coverage for a non-covered or non-formulary drug. Physicians may use Formulary Exception Form #434 and submit the request through the available Pharmacy Operations channels.

    • Formulary Exception Form #434
    Note

    Pharmacy Operations Submission Channels

    Submit the completed form and supporting clinical information to Blue Cross Blue Shield of Massachusetts Pharmacy Operations.

    • Phone: 1-800-366-7778
    • Fax: 1-800-583-6289
    • Mail: Blue Cross Blue Shield of Massachusetts Pharmacy Operations Department, 25 Technology Place, Hingham, MA 02043

    Policy Background

    This policy addresses prescription drugs excluded from the formulary because safe, comparably effective FDA-approved alternatives or generic products are available. Coverage may be considered through a formulary exception when the member is successfully maintained on the requested medication, cannot safely or effectively use covered alternatives, meets applicable clinical and step-therapy requirements, or has another qualifying clinical circumstance.

    Key Definitions

    Successful maintenance
    DefinitionSuccessful maintenance means the member has been successfully maintained on the current medication regimen, with a documented clinical basis for continuing it.
    Required documentationThe provider must submit clinical records or medication history establishing successful maintenance and explain why changing to a formulary alternative would result in instability of the medical condition.
    Clinical justification standardDocumentation is required to support the reason that switching to a formulary alternative would cause instability.
    Individual consideration
    DefinitionIndividual consideration is an exception request for coverage based on an individual member’s unique clinical circumstances when the stated coverage criteria are unlikely to be clinically effective for the prescribed purpose.
    Qualifying circumstances
    Policy Summary
    PayerBlue Cross Blue Shield - Massachusetts
    PolicyNon-Covered Drug List & Non-Covered Formulary Exception
    Policy CodePolicy 433
    Change TypeNo material change
    Effective DateAug 1, 2026
    Next Review DateN/A
    Key ActionSubmit a prior authorization and formulary exception request for coverage of a non-covered or non-formulary drug.
    SourceLink
    On This Page
    Coverage CriteriaInitial Non-Covered Drug ExceptionSuccessful Maintenance ContinuationFormulary Alternative RequirementsSubmission and Documentation RequirementsPolicy BackgroundKey Definitions
    Clinical inability to switch: The member cannot be switched to a covered formulary alternative because of another specified clinical basis or because switching would cause instability of the medical condition, such as with a narrow therapeutic index medication.

    Documentation supporting the clinical basis is required before approval.

  1. Drug shortage: The requested non-covered drug is needed because of a drug supply shortage.
  2. Brand request with generic alternative: When a brand is requested and an FDA-approved generic is a formulary alternative, documentation supports trial, failure, or contraindication of the generic.
  3. If formulary alternatives are available, the member has tried and failed at least two covered alternatives, or one covered alternative if only one is covered within the same therapeutic class for the diagnosis.
    2 alternatives, or 1 when only one is covered

    Failure may include inadequate treatment response, intolerance, clinical contraindication, allergic reaction, or adverse reaction; supporting documentation is required.

  4. Clinical inability to switch: The member cannot be switched to a covered formulary alternative because of another specified clinical basis or because switching would cause instability of the medical condition, such as with a narrow therapeutic index medication.

    Documentation supporting the clinical basis is required before approval.

  5. Drug shortage: The requested non-covered drug is needed because of a drug supply shortage.
  6. Brand request with generic alternative: When a brand is requested and the FDA-approved generic is a formulary alternative, documentation supports trial, failure, or contraindication of the generic.
  7. Step Therapy

    Formulary Alternative Trial Required

    When formulary alternatives are available, document that the member tried and failed at least two covered alternatives, or one covered alternative when only one formulary alternative is covered for the diagnosis and therapeutic class.

    • Failure may include inadequate treatment response, intolerance, allergic or adverse reaction, or clinical contraindication.
    • Provide the name and strength of each alternative tried and failed and the specific treatment-failure details.
    Step Therapy

    Combination-Drug Prerequisite

    For a non-covered combination medication, document a trial of the individual ingredients used together when those ingredients are available and covered on the formulary. If the individual agents are non-covered, trial preferred drugs in the same therapeutic class, including applicable over-the-counter alternatives.

    Step Therapy

    Brand Versus Generic Requirement

    When requesting a brand drug for which an FDA-approved generic is a formulary alternative, provide documentation showing trial and failure of, or contraindication to, the generic alternative.

    • Documentation is required for approval.
    Documentation Required

    Document Successful Maintenance

    To establish successful maintenance, provide clinical records or medication history showing that the member has been successfully maintained on the current regimen, together with clinical justification that switching to a formulary alternative would cause instability of the medical condition.

    • Documentation must support the reason for the clinical justification.
    • An exception may also apply when the member actively uses a qualifying medical device and requires non-covered diabetic test strips.
    Documentation Required

    Document Alternative Trial and Failure

    Document the alternative therapies considered or tried, including the medication names and strengths and the specific reason for treatment failure, intolerance, allergic or adverse reaction, or contraindication.

    • Include the name and strength of each alternative tried and failed, if applicable.
    • Describe the treatment response and the clinical reason the alternative cannot be used.
    Documentation Required

    Support Inability to Switch

    If the member cannot be switched to a covered formulary alternative, provide documentation supporting the specific clinical basis for avoiding the switch or preventing instability of the medical condition.

    • Examples include a narrow therapeutic index medication or another specified clinical reason.
    • Provide specific clinical details supporting why the covered alternative cannot be used.
    Documentation Required

    Supplement Incomplete Claims History

    Prescription claim records may establish successful maintenance or trial and failure of formulary alternatives. When claims data is unavailable or does not establish the applicable criteria, submit supplemental clinical records or medication history.

    • Additional information may be required when fill history is incomplete or fails to establish step-therapy criteria.
    Documentation Required

    Request Individual Consideration

    For an individual consideration request based on unique clinical circumstances, submit clinical documentation explaining why the coverage criteria are unlikely to be clinically effective for the prescribed purpose.

    • Include clinical notes or supporting clinical statements.
    • Identify formulary alternatives tried and failed, with names, strengths, and treatment-failure details, if applicable.
    • Include relevant peer-reviewed literature, drug-compendia references, or nationally recognized guidelines when available.
    Denial Risk

    Non-Covered Drug Without Qualifying Exception

    A non-covered drug generally remains non-covered when safe, comparably effective alternatives or a generic version of the brand-name product are available, unless the member qualifies for an approved exception.

    • The listed alternatives are FDA-approved and widely accepted for treating the same condition.
    Denial Risk

    Insufficient Alternative-Therapy Documentation

    A request may be denied when required alternative-therapy documentation is missing or does not establish the applicable trial-and-failure criteria.

    • Provide the required alternative names, strengths, and specific treatment-failure details.
    • Document the clinical reason preventing a trial when an alternative could not be tried.
    Denial Risk

    Clinical or Step-Therapy Criteria Not Met

    A request may be denied when the clinical or step-therapy criteria are not met, including when the requested drug lacks a supported indication, required individual-ingredient trials are absent, or required covered-alternative therapy has not been completed or documented.

    • The indication must be FDA-approved or supported by accepted compendia, guidelines, peer-reviewed evidence, or standard of care.
    • Combination products must meet the individual-ingredient prerequisite when applicable.
    Denial Risk

    Requested Product Is Listed as Non-Covered

    A requested product listed on the Non-covered Drug List may be denied unless the member meets an applicable formulary-exception criterion.

    • Review the Non-covered Drug List before submitting the request.
    • Products listed across therapeutic categories, including antineoplastic, antiparasitic, antiviral, biologic, diabetes, and other categories, may require an exception.
    Denial Risk

    Requested Drug Is Listed as Non-Covered

    A requested drug listed on the Non-covered Drug List may be denied when the submitted request does not establish a qualifying exception, including for products listed in diabetes, osteoporosis, respiratory, and other therapeutic categories.

    • Confirm the product's status on the current Non-covered Drug List and provide all required exception documentation.
    Denial Risk

    Age-Specific PPI Exclusion

    Proton pump inhibitor products are excluded for members age 18 years and older and may not be covered under this policy.

    • Review the member's age and the applicable product listing before submitting a request.
    Examples include therapeutic contraindications, a history of adverse effects, expected ineffectiveness, or a likelihood of physical, mental, or other harm.
    Supporting informationProviders should include clinical notes or supporting statements, formulary alternatives tried and failed with treatment-failure details, and relevant peer-reviewed literature, drug-compendia, consensus, or nationally sanctioned guideline references when applicable.